Arkolith/Insider Trading/CLVS/Form 4

Muehl Daniel W

See RemarksClovis Oncology, Inc. (CLVS) · full profile →Form 4 · filed Nov 3, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4K
Net Open-Market Flow
-$4K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 2, 2022Sell(S)3K$0.98$2K102K
Nov 2, 2022Sell(S)2K$0.98$2K105K
Nov 1, 2022Option exercise(M)5K——107K
Nov 1, 2022Option exercise(M)6K——105K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 1, 2022Option exercise(M)6K—$06K
Nov 1, 2022Option exercise(M)5K—$023K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-034892) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML